Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression
Anastasia G. Henry, Soheil Aghamohammadzadeh, Harry Samaroo, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 21, pp. 6013-6028
Open Access | Times Cited: 206

Showing 1-25 of 206 citing articles:

Lysosomal membrane permeabilization and cell death
Fengjuan Wang, Raquel Gómez‐Sintes, Patricia Boya
Traffic (2018) Vol. 19, Iss. 12, pp. 918-931
Open Access | Times Cited: 571
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
Heather Booth, Warren D. Hirst, Richard Wade‐Martins
Trends in Neurosciences (2017) Vol. 40, Iss. 6, pp. 358-370
Open Access | Times Cited: 515
The genetics of Parkinson disease
Hao Deng, Peng Wang, Joseph Jankovic
Ageing Research Reviews (2017) Vol. 42, pp. 72-85
Closed Access | Times Cited: 466
Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease
Daniel J. Colacurcio, Ralph A. Nixon
Ageing Research Reviews (2016) Vol. 32, pp. 75-88
Open Access | Times Cited: 429
The different autophagy degradation pathways and neurodegeneration
Angeleen Fleming, Mathieu Bourdenx, Motoki Fujimaki, et al.
Neuron (2022) Vol. 110, Iss. 6, pp. 935-966
Open Access | Times Cited: 291
Microglia and astrocyte dysfunction in parkinson's disease
Tae‐In Kam, Jared T. Hinkle, Ted M. Dawson, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105028-105028
Open Access | Times Cited: 267
The emerging mechanisms and functions of microautophagy
Liming Wang, Daniel J. Klionsky, Han‐Ming Shen
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 3, pp. 186-203
Closed Access | Times Cited: 245
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 225
LRRK2 mediates tubulation and vesicle sorting from lysosomes
Luis Bonet‐Ponce, Alexandra Beilina, Chad D. Williamson, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 205
Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
Ruby I. MacDonald, Katy Barnes, Christopher Hastings, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 4, pp. 891-909
Open Access | Times Cited: 190
LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 186
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Closed Access | Times Cited: 161
Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons
Xia Zhang, Mengping Wei, Jiahui Fan, et al.
Autophagy (2020) Vol. 17, Iss. 6, pp. 1519-1542
Open Access | Times Cited: 158
Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans
María Eugenia Goya, Feng Xue, Cristina Sampedro-Torres-Quevedo, et al.
Cell Reports (2020) Vol. 30, Iss. 2, pp. 367-380.e7
Open Access | Times Cited: 149
Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
Sebastian Virreira Winter, Özge Karayel, Maximilian T. Strauss, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 3
Open Access | Times Cited: 118
LRRK2 and idiopathic Parkinson’s disease
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases
Zhenlei Chen, Ziqi Yuan, Shangchen Yang, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 29, Iss. 1, pp. 24-36
Open Access | Times Cited: 78
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Chih Hung Lo, Jialiu Zeng
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 49
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease
Danna Jennings, Sarah Huntwork‐Rodriguez, Maurits F. J. M. Vissers, et al.
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 386-398
Open Access | Times Cited: 45
The V-ATPase–ATG16L1 axis recruits LRRK2 to facilitate the lysosomal stress response
Tomoya Eguchi, Maria Sakurai, Yingxue Wang, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 3
Open Access | Times Cited: 21
G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons
Laura A. Volpicelli‐Daley, Hisham Abdelmotilib, Zhiyong Liu, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 28, pp. 7415-7427
Open Access | Times Cited: 166
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
Experimental Neurology (2017) Vol. 298, pp. 236-245
Open Access | Times Cited: 152
Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to α-Synuclein Gain
Guang Lin, Pei-Tseng Lee, Kuchuan Chen, et al.
Cell Metabolism (2018) Vol. 28, Iss. 4, pp. 605-618.e6
Open Access | Times Cited: 151
Endocytic membrane trafficking and neurodegenerative disease
Andrea M. A. Schreij, Edward A. Fon, Peter S. McPherson
Cellular and Molecular Life Sciences (2015) Vol. 73, Iss. 8, pp. 1529-1545
Open Access | Times Cited: 142
Autophagy impairment in Parkinson’s disease
Cansu Karabiyik, Min Jae Lee, David C. Rubinsztein
Essays in Biochemistry (2017) Vol. 61, Iss. 6, pp. 711-720
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top